Review





Similar Products

97
R&D Systems nmol l tumor necrosis factor
Nmol L Tumor Necrosis Factor, supplied by R&D Systems, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+%CE%B1+-cgrp/Recombinant+Human+TNF-alpha+Protein/pmc13054578-103-43-49
Average 97 stars, based on 1 article reviews
nmol l tumor necrosis factor - by Bioz Stars, 2026-11
97/100 stars
  Buy from Supplier

94
R&D Systems nanog
Nanog, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+%CE%B1+-cgrp/Human+Nanog+Antibody/pmc13774481-134-20-23
Average 94 stars, based on 1 article reviews
nanog - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

94
Miltenyi Biotec cd4 microbeads
( A–D ) Analysis of the CD8 + T-cell compartment in WT and Itk⁻ / ⁻ mice. Freshly isolated splenocytes were gated on CD3 + lymphocytes and further subdivided into CD8 + and <t>CD4</t> + T-cell populations. ( A ) Representative flow cytometry plots showing CD44 and CD62L expression within CD8 + T cells. ( B–D ) Quantification of effector memory (EM; CD44 + CD62L⁻), central memory (CM; CD44 + CD62L + ), and naive (CD44⁻CD62L + ) CD8 + T-cell subsets. ( E–H ) Analysis of the CD4 + T-cell compartment. ( E ) Representative flow cytometry plots showing CD44 and CD62L expression within CD4 + T cells. ( F–H ) Quantification of EM, CM, and naive CD4 + T-cell frequencies. Data are presented as mean ± SEM ( n = 10–15 mice per group). Results are representative of six independent experiments. Statistical significance was determined by an unpaired two-tailed Student’s t -test. ****p ≤ 0.0001; ns, not significant (p > 0.05).
Cd4 Microbeads, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+%CE%B1+-cgrp/CD304+(BDCA-4)+Antibody%2C+anti-human/pmc13777272-245-11-13
Average 94 stars, based on 1 article reviews
cd4 microbeads - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

95
SouthernBiotech igg2a antibodies
Overall animal experiments and immune evaluations in mice. Two independent mouse studies were conducted to evaluate the immunogenicity and efficacy of the rCapC vaccine candidate. Study 1 (dose‐finding, n = 5 per group): mice were intramuscularly (IM) immunized with different doses of rCapC (5, 25, or 50 μg/dose) formulated with ISA 201 adjuvant, while the control group received PBS. Primary and booster vaccinations were administered at weeks 0 and 2, respectively. Blood samples were collected at weeks 0, 2, 4, 6, and 8 to determine antigen‐specific IgG responses against PCV2 and rCap‐PCV3. Study 2 (efficacy test, n = 12 per group): mice were IM immunized with 25 μg rCapC (ISA 201), a commercial vaccine (ISA 206), or PBS control. Primary and booster vaccinations were given at weeks 0 and 2. Blood samples were collected at weeks 0, 2, 4, 8, 12, and 16. Humoral immune responses, including total IgG, IgG1, and <t>IgG2a,</t> were measured at all time points. Additionally, cellular immune responses (CD4 + T cells) and cytokine profiles were evaluated at selected time points (weeks 2 and 4).
Igg2a Antibodies, supplied by SouthernBiotech, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+%CE%B1+-cgrp/Goat+Anti-Mouse+IgG2a%2C+Human+ads-HRP/pmc13775159-102-12-16
Average 95 stars, based on 1 article reviews
igg2a antibodies - by Bioz Stars, 2026-11
95/100 stars
  Buy from Supplier

96
SouthernBiotech hrp conjugated goat anti mouse igg1
Overall animal experiments and immune evaluations in mice. Two independent mouse studies were conducted to evaluate the immunogenicity and efficacy of the rCapC vaccine candidate. Study 1 (dose‐finding, n = 5 per group): mice were intramuscularly (IM) immunized with different doses of rCapC (5, 25, or 50 μg/dose) formulated with ISA 201 adjuvant, while the control group received PBS. Primary and booster vaccinations were administered at weeks 0 and 2, respectively. Blood samples were collected at weeks 0, 2, 4, 6, and 8 to determine antigen‐specific <t>IgG</t> responses against PCV2 and rCap‐PCV3. Study 2 (efficacy test, n = 12 per group): mice were IM immunized with 25 μg rCapC (ISA 201), a commercial vaccine (ISA 206), or PBS control. Primary and booster vaccinations were given at weeks 0 and 2. Blood samples were collected at weeks 0, 2, 4, 8, 12, and 16. Humoral immune responses, including total IgG, <t>IgG1,</t> and <t>IgG2a,</t> were measured at all time points. Additionally, cellular immune responses (CD4 + T cells) and cytokine profiles were evaluated at selected time points (weeks 2 and 4).
Hrp Conjugated Goat Anti Mouse Igg1, supplied by SouthernBiotech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+%CE%B1+-cgrp/Goat+Anti-Mouse+IgG1%2C+Human+ads-HRP/pmc13775159-102-7-16
Average 96 stars, based on 1 article reviews
hrp conjugated goat anti mouse igg1 - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

93
R&D Systems human tgf beta 1 quantikine elisa kit
Overall animal experiments and immune evaluations in mice. Two independent mouse studies were conducted to evaluate the immunogenicity and efficacy of the rCapC vaccine candidate. Study 1 (dose‐finding, n = 5 per group): mice were intramuscularly (IM) immunized with different doses of rCapC (5, 25, or 50 μg/dose) formulated with ISA 201 adjuvant, while the control group received PBS. Primary and booster vaccinations were administered at weeks 0 and 2, respectively. Blood samples were collected at weeks 0, 2, 4, 6, and 8 to determine antigen‐specific <t>IgG</t> responses against PCV2 and rCap‐PCV3. Study 2 (efficacy test, n = 12 per group): mice were IM immunized with 25 μg rCapC (ISA 201), a commercial vaccine (ISA 206), or PBS control. Primary and booster vaccinations were given at weeks 0 and 2. Blood samples were collected at weeks 0, 2, 4, 8, 12, and 16. Humoral immune responses, including total IgG, <t>IgG1,</t> and <t>IgG2a,</t> were measured at all time points. Additionally, cellular immune responses (CD4 + T cells) and cytokine profiles were evaluated at selected time points (weeks 2 and 4).
Human Tgf Beta 1 Quantikine Elisa Kit, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+%CE%B1+-cgrp/Human+TGF-alpha+Quantikine+ELISA+Kit/pmc13774782-117-9-15
Average 93 stars, based on 1 article reviews
human tgf beta 1 quantikine elisa kit - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

94
Cedarlane mouse anti human c3 c3b ic3b antibody
Overall animal experiments and immune evaluations in mice. Two independent mouse studies were conducted to evaluate the immunogenicity and efficacy of the rCapC vaccine candidate. Study 1 (dose‐finding, n = 5 per group): mice were intramuscularly (IM) immunized with different doses of rCapC (5, 25, or 50 μg/dose) formulated with ISA 201 adjuvant, while the control group received PBS. Primary and booster vaccinations were administered at weeks 0 and 2, respectively. Blood samples were collected at weeks 0, 2, 4, 6, and 8 to determine antigen‐specific <t>IgG</t> responses against PCV2 and rCap‐PCV3. Study 2 (efficacy test, n = 12 per group): mice were IM immunized with 25 μg rCapC (ISA 201), a commercial vaccine (ISA 206), or PBS control. Primary and booster vaccinations were given at weeks 0 and 2. Blood samples were collected at weeks 0, 2, 4, 8, 12, and 16. Humoral immune responses, including total IgG, <t>IgG1,</t> and <t>IgG2a,</t> were measured at all time points. Additionally, cellular immune responses (CD4 + T cells) and cytokine profiles were evaluated at selected time points (weeks 2 and 4).
Mouse Anti Human C3 C3b Ic3b Antibody, supplied by Cedarlane, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+%CE%B1+-cgrp/Anti-Human%2FMouse+C3%2FC3b%2FiC3b%2C+APC+(Clone%3A+6C9)+(mouse+IgG1)/pmc13771829-167-11-16
Average 94 stars, based on 1 article reviews
mouse anti human c3 c3b ic3b antibody - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

93
R&D Systems mouse monoclonal anti human esrrg nr3b3 esrrg
Overall animal experiments and immune evaluations in mice. Two independent mouse studies were conducted to evaluate the immunogenicity and efficacy of the rCapC vaccine candidate. Study 1 (dose‐finding, n = 5 per group): mice were intramuscularly (IM) immunized with different doses of rCapC (5, 25, or 50 μg/dose) formulated with ISA 201 adjuvant, while the control group received PBS. Primary and booster vaccinations were administered at weeks 0 and 2, respectively. Blood samples were collected at weeks 0, 2, 4, 6, and 8 to determine antigen‐specific <t>IgG</t> responses against PCV2 and rCap‐PCV3. Study 2 (efficacy test, n = 12 per group): mice were IM immunized with 25 μg rCapC (ISA 201), a commercial vaccine (ISA 206), or PBS control. Primary and booster vaccinations were given at weeks 0 and 2. Blood samples were collected at weeks 0, 2, 4, 8, 12, and 16. Humoral immune responses, including total IgG, <t>IgG1,</t> and <t>IgG2a,</t> were measured at all time points. Additionally, cellular immune responses (CD4 + T cells) and cytokine profiles were evaluated at selected time points (weeks 2 and 4).
Mouse Monoclonal Anti Human Esrrg Nr3b3 Esrrg, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+%CE%B1+-cgrp/Human+ERR+gamma%2FNR3B3+Antibody/pm43036312-57-20-25
Average 93 stars, based on 1 article reviews
mouse monoclonal anti human esrrg nr3b3 esrrg - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

93
R&D Systems pp a8620a
Overall animal experiments and immune evaluations in mice. Two independent mouse studies were conducted to evaluate the immunogenicity and efficacy of the rCapC vaccine candidate. Study 1 (dose‐finding, n = 5 per group): mice were intramuscularly (IM) immunized with different doses of rCapC (5, 25, or 50 μg/dose) formulated with ISA 201 adjuvant, while the control group received PBS. Primary and booster vaccinations were administered at weeks 0 and 2, respectively. Blood samples were collected at weeks 0, 2, 4, 6, and 8 to determine antigen‐specific <t>IgG</t> responses against PCV2 and rCap‐PCV3. Study 2 (efficacy test, n = 12 per group): mice were IM immunized with 25 μg rCapC (ISA 201), a commercial vaccine (ISA 206), or PBS control. Primary and booster vaccinations were given at weeks 0 and 2. Blood samples were collected at weeks 0, 2, 4, 8, 12, and 16. Humoral immune responses, including total IgG, <t>IgG1,</t> and <t>IgG2a,</t> were measured at all time points. Additionally, cellular immune responses (CD4 + T cells) and cytokine profiles were evaluated at selected time points (weeks 2 and 4).
Pp A8620a, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+%CE%B1+-cgrp/Human%2FMouse+G9a%2FEHMT2+Antibody/pmc13774038-235-73-74
Average 93 stars, based on 1 article reviews
pp a8620a - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

94
ABclonal Biotechnology anti human cd3 antibody
KRN2 inhibits NFAT5 and downregulates PD‐1 expression in CD8+ T cells. Note: (A) Workflow showing the isolation, activation, expansion, and grouping of CD8 + T cells from hPBMCs. Created using BioRender. (B) RT‐qPCR and Western blot analyses of NFAT5 and PD‐1 mRNA and protein expression levels. (C) RT‐qPCR and Western blot detection of NFAT5 and PD‐1 mRNA and protein expression following NFAT5 knockdown. (D) Dual‐luciferase reporter assay assessing the effect of NFAT5 on PD‐1 transcriptional activity. (E) ChIP assay examining NFAT5 binding to the PD‐1 promoter region. All experiments were independently repeated three times. ns, not significant; * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001.
Anti Human Cd3 Antibody, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+%CE%B1+-cgrp/CD3+epsilon+Rabbit+mAb/pmc13770899-76-10-14
Average 94 stars, based on 1 article reviews
anti human cd3 antibody - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

Image Search Results


( A–D ) Analysis of the CD8 + T-cell compartment in WT and Itk⁻ / ⁻ mice. Freshly isolated splenocytes were gated on CD3 + lymphocytes and further subdivided into CD8 + and CD4 + T-cell populations. ( A ) Representative flow cytometry plots showing CD44 and CD62L expression within CD8 + T cells. ( B–D ) Quantification of effector memory (EM; CD44 + CD62L⁻), central memory (CM; CD44 + CD62L + ), and naive (CD44⁻CD62L + ) CD8 + T-cell subsets. ( E–H ) Analysis of the CD4 + T-cell compartment. ( E ) Representative flow cytometry plots showing CD44 and CD62L expression within CD4 + T cells. ( F–H ) Quantification of EM, CM, and naive CD4 + T-cell frequencies. Data are presented as mean ± SEM ( n = 10–15 mice per group). Results are representative of six independent experiments. Statistical significance was determined by an unpaired two-tailed Student’s t -test. ****p ≤ 0.0001; ns, not significant (p > 0.05).

Journal: eLife

Article Title: ITK deficiency protects against autoimmune pulmonary hemorrhage in mice by promoting amphiregulin-producing regulatory T cells

doi: 10.7554/eLife.111915

Figure Lengend Snippet: ( A–D ) Analysis of the CD8 + T-cell compartment in WT and Itk⁻ / ⁻ mice. Freshly isolated splenocytes were gated on CD3 + lymphocytes and further subdivided into CD8 + and CD4 + T-cell populations. ( A ) Representative flow cytometry plots showing CD44 and CD62L expression within CD8 + T cells. ( B–D ) Quantification of effector memory (EM; CD44 + CD62L⁻), central memory (CM; CD44 + CD62L + ), and naive (CD44⁻CD62L + ) CD8 + T-cell subsets. ( E–H ) Analysis of the CD4 + T-cell compartment. ( E ) Representative flow cytometry plots showing CD44 and CD62L expression within CD4 + T cells. ( F–H ) Quantification of EM, CM, and naive CD4 + T-cell frequencies. Data are presented as mean ± SEM ( n = 10–15 mice per group). Results are representative of six independent experiments. Statistical significance was determined by an unpaired two-tailed Student’s t -test. ****p ≤ 0.0001; ns, not significant (p > 0.05).

Article Snippet: Lung CD4 + T cells were then enriched by MACS using CD4 microbeads (Miltenyi Biotec; Cat# 130-114-043).

Techniques: Analysis, Isolation, Flow Cytometry, Expressing, Two Tailed Test

Freshly isolated splenocytes from WT ( A–G ) and Itk⁻ / ⁻ ( H–N ) mice were analyzed by flow cytometry. ( A, H ) Lymphocyte populations were initially gated based on side scatter area (SSC-A) versus forward scatter area (FSC-A). ( B, I ) Lymphocytes were then gated for single cells using forward scatter height (FSC-H) versus forward scatter width (FSC-W) to discriminate doublets. ( C, J ) Additional singlet gating was performed using side scatter height (SSC-H) versus side scatter width (SSC-W) to exclude any remaining doublets. ( D, K ) CD3 + T lymphocytes were identified from the single-cell population based on SSC-A versus CD3 expression. ( E, L ) The CD3 + compartment was further subdivided into CD8 + and CD4 + T-cell populations. ( F, M ) CD8 + and ( G, N ) CD4 + T cells were then analyzed to identify and quantify effector memory (EM; CD44 + CD62L⁻), central memory (CM; CD44 + CD62L + ), and naive (CD44⁻CD62L + ) subsets, as depicted in the contour plots.

Journal: eLife

Article Title: ITK deficiency protects against autoimmune pulmonary hemorrhage in mice by promoting amphiregulin-producing regulatory T cells

doi: 10.7554/eLife.111915

Figure Lengend Snippet: Freshly isolated splenocytes from WT ( A–G ) and Itk⁻ / ⁻ ( H–N ) mice were analyzed by flow cytometry. ( A, H ) Lymphocyte populations were initially gated based on side scatter area (SSC-A) versus forward scatter area (FSC-A). ( B, I ) Lymphocytes were then gated for single cells using forward scatter height (FSC-H) versus forward scatter width (FSC-W) to discriminate doublets. ( C, J ) Additional singlet gating was performed using side scatter height (SSC-H) versus side scatter width (SSC-W) to exclude any remaining doublets. ( D, K ) CD3 + T lymphocytes were identified from the single-cell population based on SSC-A versus CD3 expression. ( E, L ) The CD3 + compartment was further subdivided into CD8 + and CD4 + T-cell populations. ( F, M ) CD8 + and ( G, N ) CD4 + T cells were then analyzed to identify and quantify effector memory (EM; CD44 + CD62L⁻), central memory (CM; CD44 + CD62L + ), and naive (CD44⁻CD62L + ) subsets, as depicted in the contour plots.

Article Snippet: Lung CD4 + T cells were then enriched by MACS using CD4 microbeads (Miltenyi Biotec; Cat# 130-114-043).

Techniques: Isolation, Flow Cytometry, Single Cell, Expressing

( A, B ) Surface expression of CD44 on splenic CD4 + T cells. Representative flow cytometry plots ( A ) and quantification of CD44 + frequencies ( B ) in WT and Itk⁻ / ⁻ mice. ( C, D ) Expression of the T-box transcription factor Eomes. Representative flow cytometry plots ( C ) and quantification of total Eomes + CD4 + T cells ( D ) within the CD3 + CD4 + gate. ( E, F ) Surface expression of CD122 (IL-2Rβ). Representative flow cytometry plots ( E ) and quantification of CD122 frequencies on CD4 + T cells ( F ) from WT and Itk⁻ / ⁻ mice. ( G, H ) Intracellular expression of the transcription factor T-bet. Representative flow cytometry plots ( G ) and quantification of T-bet frequencies within the CD3 + CD4 + population ( H ). Data are presented as mean ± SEM ( n = 15–20 mice per group). Results are representative of at least three independent experiments. Statistical significance was determined by an unpaired two-tailed Student’s t -test ***p < 0.001, *p ≤ 0.05, ****p < 0.0001, **p ≤ 0.01.

Journal: eLife

Article Title: ITK deficiency protects against autoimmune pulmonary hemorrhage in mice by promoting amphiregulin-producing regulatory T cells

doi: 10.7554/eLife.111915

Figure Lengend Snippet: ( A, B ) Surface expression of CD44 on splenic CD4 + T cells. Representative flow cytometry plots ( A ) and quantification of CD44 + frequencies ( B ) in WT and Itk⁻ / ⁻ mice. ( C, D ) Expression of the T-box transcription factor Eomes. Representative flow cytometry plots ( C ) and quantification of total Eomes + CD4 + T cells ( D ) within the CD3 + CD4 + gate. ( E, F ) Surface expression of CD122 (IL-2Rβ). Representative flow cytometry plots ( E ) and quantification of CD122 frequencies on CD4 + T cells ( F ) from WT and Itk⁻ / ⁻ mice. ( G, H ) Intracellular expression of the transcription factor T-bet. Representative flow cytometry plots ( G ) and quantification of T-bet frequencies within the CD3 + CD4 + population ( H ). Data are presented as mean ± SEM ( n = 15–20 mice per group). Results are representative of at least three independent experiments. Statistical significance was determined by an unpaired two-tailed Student’s t -test ***p < 0.001, *p ≤ 0.05, ****p < 0.0001, **p ≤ 0.01.

Article Snippet: Lung CD4 + T cells were then enriched by MACS using CD4 microbeads (Miltenyi Biotec; Cat# 130-114-043).

Techniques: Expressing, Flow Cytometry, Two Tailed Test

( A ) Representative flow cytometry plots and quantitative analysis of splenic CD4 + Foxp3 + Tregs in WT and Itk⁻ / ⁻ mice. ( B–D ) Experimental schematic for Treg adoptive transfer. ( B ) WT mice (CD45.1 + ) received a single i.p. injection of 0.5 ml pristane. ( C ) On day 10, CD4 + Foxp3 + Tregs were FACS-sorted from WT or Itk⁻ / ⁻ donor mice (CD45.2 + ), with post-sort purity confirmed as CD25 + Foxp3 + . These cells were injected intravenously (i.v.) into the pristane-treated CD45.1 + recipients as a therapeutic intervention. ( D ) On day 21, CD45.1 + host mice were euthanized for examination of the lungs and draining lymph nodes (dLNs). ( E ) Representative flow cytometry plots and quantitative analysis of lung CD4 + Foxp3 + Tregs in WT and Itk⁻ / ⁻ mice at baseline (without pristane injection). Representative flow cytometry plots and quantitative analysis of total donor CD45.2 + cells ( F ) and donor-derived Tregs ( G ) engrafted in the lungs of CD45.1 + recipient mice. Representative flow cytometry plots and quantitative analysis of total donor CD45.2 + cells ( H ) and donor-derived Tregs ( I ) in the dLNs of CD45.1 + recipient mice. ( J ) Immunofluorescence microscopy of lung sections confirming the presence of donor Tregs in inflamed lung tissue. Sections were stained for CD4, the donor congenic marker (CD45.2), and Foxp3, with merged images demonstrating colocalization; nuclei were counterstained with DAPI. ( K ) CD25 + Foxp3 + Tregs were FACS-sorted from lung tissue and analyzed by immunoblot for amphiregulin (AREG), with β-actin as a loading control. Data are presented as mean ± SEM; sample sizes ( n = 15–25 mice per group) are indicated in the panels. Each experiment was repeated three times. Statistical significance was determined using a two-tailed Student’s t -test, one-way ANOVA, or two-way ANOVA as appropriate; p < 0.01, ***p < 0.001, *p ≤ 0.05, ****p < 0.0001, **p ≤ 0.01. Figure 5—source data 1. Raw, uncropped western blot images shown in . Figure 5—source data 2. Uncropped western blot images shown in , labelled.

Journal: eLife

Article Title: ITK deficiency protects against autoimmune pulmonary hemorrhage in mice by promoting amphiregulin-producing regulatory T cells

doi: 10.7554/eLife.111915

Figure Lengend Snippet: ( A ) Representative flow cytometry plots and quantitative analysis of splenic CD4 + Foxp3 + Tregs in WT and Itk⁻ / ⁻ mice. ( B–D ) Experimental schematic for Treg adoptive transfer. ( B ) WT mice (CD45.1 + ) received a single i.p. injection of 0.5 ml pristane. ( C ) On day 10, CD4 + Foxp3 + Tregs were FACS-sorted from WT or Itk⁻ / ⁻ donor mice (CD45.2 + ), with post-sort purity confirmed as CD25 + Foxp3 + . These cells were injected intravenously (i.v.) into the pristane-treated CD45.1 + recipients as a therapeutic intervention. ( D ) On day 21, CD45.1 + host mice were euthanized for examination of the lungs and draining lymph nodes (dLNs). ( E ) Representative flow cytometry plots and quantitative analysis of lung CD4 + Foxp3 + Tregs in WT and Itk⁻ / ⁻ mice at baseline (without pristane injection). Representative flow cytometry plots and quantitative analysis of total donor CD45.2 + cells ( F ) and donor-derived Tregs ( G ) engrafted in the lungs of CD45.1 + recipient mice. Representative flow cytometry plots and quantitative analysis of total donor CD45.2 + cells ( H ) and donor-derived Tregs ( I ) in the dLNs of CD45.1 + recipient mice. ( J ) Immunofluorescence microscopy of lung sections confirming the presence of donor Tregs in inflamed lung tissue. Sections were stained for CD4, the donor congenic marker (CD45.2), and Foxp3, with merged images demonstrating colocalization; nuclei were counterstained with DAPI. ( K ) CD25 + Foxp3 + Tregs were FACS-sorted from lung tissue and analyzed by immunoblot for amphiregulin (AREG), with β-actin as a loading control. Data are presented as mean ± SEM; sample sizes ( n = 15–25 mice per group) are indicated in the panels. Each experiment was repeated three times. Statistical significance was determined using a two-tailed Student’s t -test, one-way ANOVA, or two-way ANOVA as appropriate; p < 0.01, ***p < 0.001, *p ≤ 0.05, ****p < 0.0001, **p ≤ 0.01. Figure 5—source data 1. Raw, uncropped western blot images shown in . Figure 5—source data 2. Uncropped western blot images shown in , labelled.

Article Snippet: Lung CD4 + T cells were then enriched by MACS using CD4 microbeads (Miltenyi Biotec; Cat# 130-114-043).

Techniques: Flow Cytometry, Analysis, Adoptive Transfer Assay, Injection, Derivative Assay, Immunofluorescence, Microscopy, Tissue, Staining, Marker, Western Blot, Control, Two Tailed Test

( A, B ) Quantitative analysis of Treg subsets at baseline. Representative flow cytometry plots ( A ) and statistical quantification ( B ) of freshly isolated splenic regulatory T cells from WT and Itk⁻ / ⁻ mice. Tregs were identified as CD3 + CD4 + Foxp3 + cells. ITK deficiency led to a significant increase in the frequency and absolute number of non-canonical (CD25⁻) Tregs compared with WT controls, while maintaining the canonical (CD25 + ) population. This expansion contributes to the broader regulatory reservoir observed in Itk⁻ / ⁻ mice. Data are presented as mean ± SEM ( n = 15–20 mice per group). Results are representative of three independent experiments. Statistical significance was determined by an unpaired two-tailed Student’s t -test. ****p ≤ 0.0001.

Journal: eLife

Article Title: ITK deficiency protects against autoimmune pulmonary hemorrhage in mice by promoting amphiregulin-producing regulatory T cells

doi: 10.7554/eLife.111915

Figure Lengend Snippet: ( A, B ) Quantitative analysis of Treg subsets at baseline. Representative flow cytometry plots ( A ) and statistical quantification ( B ) of freshly isolated splenic regulatory T cells from WT and Itk⁻ / ⁻ mice. Tregs were identified as CD3 + CD4 + Foxp3 + cells. ITK deficiency led to a significant increase in the frequency and absolute number of non-canonical (CD25⁻) Tregs compared with WT controls, while maintaining the canonical (CD25 + ) population. This expansion contributes to the broader regulatory reservoir observed in Itk⁻ / ⁻ mice. Data are presented as mean ± SEM ( n = 15–20 mice per group). Results are representative of three independent experiments. Statistical significance was determined by an unpaired two-tailed Student’s t -test. ****p ≤ 0.0001.

Article Snippet: Lung CD4 + T cells were then enriched by MACS using CD4 microbeads (Miltenyi Biotec; Cat# 130-114-043).

Techniques: Analysis, Flow Cytometry, Isolation, Two Tailed Test

( A–D ) Experimental schematic for the therapeutic adoptive transfer model. ( A ) Baseline serum and urine were collected from WT host mice (CD45.1 + ), followed by a single i.p. injection of 0.5 ml pristane. ( B, C ) On day 10, CD4 + Foxp3 + Tregs were FACS-sorted from WT or Itk⁻ / ⁻ donor mice (CD45.2 + ), confirmed positive for CD25 and Foxp3, and injected i.v. into the pristane-treated CD45.1 + recipients. A control group of pristane-challenged CD45.1 + mice was left untreated. ( D ) On day 21, host mice were euthanized and analyzed for urinary protein and gross anatomical damage to the lungs. ( E–G ) Evaluation of therapeutic efficacy in lung and kidney injury. Representative gross lung images and longitudinal quantification of urinary protein (day 0 versus day 21) are shown for ( E ) untreated pristane-challenged mice, ( F ) mice treated with WT Tregs, and ( G ) mice treated with Itk -/- Tregs. ( H–L ) Suppression of systemic inflammatory responses. Serum levels of proinflammatory cytokines (IFN-γ, TNF-α, IL-6, and IL-17) and the pro-resolving mediator IL-10 were quantified at baseline and day 21. Itk⁻ / ⁻ Tregs promoted a high-IL-10 regulatory environment while effectively suppressing the proinflammatory cytokine response. Data are presented as mean ± SEM ( n = 15–25 mice per group). Results are representative of three independent experiments. Statistical significance was determined by a two-tailed Student’s t -test or a two-way ANOVA with Tukey’s post hoc correction. ns, P >0.05; *p ≤ 0.05; p ≤ 0.01; ****p ≤ 0.001; **p ≤ 0.01, *****p ≤ 0.0001.

Journal: eLife

Article Title: ITK deficiency protects against autoimmune pulmonary hemorrhage in mice by promoting amphiregulin-producing regulatory T cells

doi: 10.7554/eLife.111915

Figure Lengend Snippet: ( A–D ) Experimental schematic for the therapeutic adoptive transfer model. ( A ) Baseline serum and urine were collected from WT host mice (CD45.1 + ), followed by a single i.p. injection of 0.5 ml pristane. ( B, C ) On day 10, CD4 + Foxp3 + Tregs were FACS-sorted from WT or Itk⁻ / ⁻ donor mice (CD45.2 + ), confirmed positive for CD25 and Foxp3, and injected i.v. into the pristane-treated CD45.1 + recipients. A control group of pristane-challenged CD45.1 + mice was left untreated. ( D ) On day 21, host mice were euthanized and analyzed for urinary protein and gross anatomical damage to the lungs. ( E–G ) Evaluation of therapeutic efficacy in lung and kidney injury. Representative gross lung images and longitudinal quantification of urinary protein (day 0 versus day 21) are shown for ( E ) untreated pristane-challenged mice, ( F ) mice treated with WT Tregs, and ( G ) mice treated with Itk -/- Tregs. ( H–L ) Suppression of systemic inflammatory responses. Serum levels of proinflammatory cytokines (IFN-γ, TNF-α, IL-6, and IL-17) and the pro-resolving mediator IL-10 were quantified at baseline and day 21. Itk⁻ / ⁻ Tregs promoted a high-IL-10 regulatory environment while effectively suppressing the proinflammatory cytokine response. Data are presented as mean ± SEM ( n = 15–25 mice per group). Results are representative of three independent experiments. Statistical significance was determined by a two-tailed Student’s t -test or a two-way ANOVA with Tukey’s post hoc correction. ns, P >0.05; *p ≤ 0.05; p ≤ 0.01; ****p ≤ 0.001; **p ≤ 0.01, *****p ≤ 0.0001.

Article Snippet: Lung CD4 + T cells were then enriched by MACS using CD4 microbeads (Miltenyi Biotec; Cat# 130-114-043).

Techniques: Adoptive Transfer Assay, Injection, Control, Drug discovery, Two Tailed Test

( A ) Global transcriptomic relationships. Principal component analysis (PCA) of transcriptomes from WT and Itk⁻ / ⁻ canonical (CD25 + ) and non-canonical (CD25⁻) Tregs. All replicates are shown ( n = 3). ( B ) Table showing the number of up- or downregulated differentially expressed genes (DEGs) between groups. ( C, D ) Transcriptomic landscape of ITK-deficient Tregs. Volcano plots identify the top DEGs between Itk⁻ / ⁻ and WT Tregs. Genes meeting the thresholds of false discovery rate (FDR) ≤0.05 and |log₂FC| ≥0.5 are highlighted, with a positive log₂FC indicating enrichment in Itk⁻ / ⁻ canonical ( C ) and non-canonical ( D ) Tregs. ( E, F ) Hierarchical clustering heatmaps showing row-scaled normalized expression of all significant DEGs in canonical CD4 + CD25 + Foxp3 + Tregs from WT and Itk⁻ / ⁻ mice ( n = 3 per group). A grey bar indicates WT, orange indicates the canonical group, and green indicates the non-canonical group. ( G ) Tables showing Gene Ontology (GO) enrichment analysis of the DEGs from Itk⁻ / ⁻ canonical (CD25 + ) and non-canonical (CD25⁻) Tregs. Using the online tool gProfiler and the ordered g:GOSt query, we assessed which biological processes (BP) were linked to the genes in the different modules from Itk⁻ / ⁻ and WT mice. In the table, p-values are color-coded from light blue (not significant) to orange (highest significance) ( n = 3 mice per group). Gene Set Enrichment Analysis (GSEA) of regulatory pathways in canonical ( H ) and non-canonical ( I ) samples. Ridge plots show the distribution of ranked DESeq2 Wald statistic values for selected Hallmark pathways, including oxidative phosphorylation (OXPHOS), mTORC1 signaling, and MYC targets, which together reflect enhanced metabolic fitness in ITK-deficient regulatory subsets.

Journal: eLife

Article Title: ITK deficiency protects against autoimmune pulmonary hemorrhage in mice by promoting amphiregulin-producing regulatory T cells

doi: 10.7554/eLife.111915

Figure Lengend Snippet: ( A ) Global transcriptomic relationships. Principal component analysis (PCA) of transcriptomes from WT and Itk⁻ / ⁻ canonical (CD25 + ) and non-canonical (CD25⁻) Tregs. All replicates are shown ( n = 3). ( B ) Table showing the number of up- or downregulated differentially expressed genes (DEGs) between groups. ( C, D ) Transcriptomic landscape of ITK-deficient Tregs. Volcano plots identify the top DEGs between Itk⁻ / ⁻ and WT Tregs. Genes meeting the thresholds of false discovery rate (FDR) ≤0.05 and |log₂FC| ≥0.5 are highlighted, with a positive log₂FC indicating enrichment in Itk⁻ / ⁻ canonical ( C ) and non-canonical ( D ) Tregs. ( E, F ) Hierarchical clustering heatmaps showing row-scaled normalized expression of all significant DEGs in canonical CD4 + CD25 + Foxp3 + Tregs from WT and Itk⁻ / ⁻ mice ( n = 3 per group). A grey bar indicates WT, orange indicates the canonical group, and green indicates the non-canonical group. ( G ) Tables showing Gene Ontology (GO) enrichment analysis of the DEGs from Itk⁻ / ⁻ canonical (CD25 + ) and non-canonical (CD25⁻) Tregs. Using the online tool gProfiler and the ordered g:GOSt query, we assessed which biological processes (BP) were linked to the genes in the different modules from Itk⁻ / ⁻ and WT mice. In the table, p-values are color-coded from light blue (not significant) to orange (highest significance) ( n = 3 mice per group). Gene Set Enrichment Analysis (GSEA) of regulatory pathways in canonical ( H ) and non-canonical ( I ) samples. Ridge plots show the distribution of ranked DESeq2 Wald statistic values for selected Hallmark pathways, including oxidative phosphorylation (OXPHOS), mTORC1 signaling, and MYC targets, which together reflect enhanced metabolic fitness in ITK-deficient regulatory subsets.

Article Snippet: Lung CD4 + T cells were then enriched by MACS using CD4 microbeads (Miltenyi Biotec; Cat# 130-114-043).

Techniques: Analysis, Expressing, Gene Set Enrichment Analysis, Phospho-proteomics

Overall animal experiments and immune evaluations in mice. Two independent mouse studies were conducted to evaluate the immunogenicity and efficacy of the rCapC vaccine candidate. Study 1 (dose‐finding, n = 5 per group): mice were intramuscularly (IM) immunized with different doses of rCapC (5, 25, or 50 μg/dose) formulated with ISA 201 adjuvant, while the control group received PBS. Primary and booster vaccinations were administered at weeks 0 and 2, respectively. Blood samples were collected at weeks 0, 2, 4, 6, and 8 to determine antigen‐specific IgG responses against PCV2 and rCap‐PCV3. Study 2 (efficacy test, n = 12 per group): mice were IM immunized with 25 μg rCapC (ISA 201), a commercial vaccine (ISA 206), or PBS control. Primary and booster vaccinations were given at weeks 0 and 2. Blood samples were collected at weeks 0, 2, 4, 8, 12, and 16. Humoral immune responses, including total IgG, IgG1, and IgG2a, were measured at all time points. Additionally, cellular immune responses (CD4 + T cells) and cytokine profiles were evaluated at selected time points (weeks 2 and 4).

Journal: Transboundary and Emerging Diseases

Article Title: Porcine Circoviruses Type 2 and 3 Chimeric Novel Vaccine Candidate Formed Virus‐Like Particles and Induced Robust Immune Response in Mice

doi: 10.1155/tbed/4119771

Figure Lengend Snippet: Overall animal experiments and immune evaluations in mice. Two independent mouse studies were conducted to evaluate the immunogenicity and efficacy of the rCapC vaccine candidate. Study 1 (dose‐finding, n = 5 per group): mice were intramuscularly (IM) immunized with different doses of rCapC (5, 25, or 50 μg/dose) formulated with ISA 201 adjuvant, while the control group received PBS. Primary and booster vaccinations were administered at weeks 0 and 2, respectively. Blood samples were collected at weeks 0, 2, 4, 6, and 8 to determine antigen‐specific IgG responses against PCV2 and rCap‐PCV3. Study 2 (efficacy test, n = 12 per group): mice were IM immunized with 25 μg rCapC (ISA 201), a commercial vaccine (ISA 206), or PBS control. Primary and booster vaccinations were given at weeks 0 and 2. Blood samples were collected at weeks 0, 2, 4, 8, 12, and 16. Humoral immune responses, including total IgG, IgG1, and IgG2a, were measured at all time points. Additionally, cellular immune responses (CD4 + T cells) and cytokine profiles were evaluated at selected time points (weeks 2 and 4).

Article Snippet: Instead of the anti‐mouse IgG secondary antibody, HRP‐conjugated goat anti‐mouse IgG1 and IgG2a antibodies (1:5000 dilution; SouthernBiotech, Birmingham, AL, USA) were used.

Techniques: Immunopeptidomics, Adjuvant, Control, Blood/Plasma/Serum Samples

Dose‐dependent specific IgG antibody responses against PCV2 and PCV3. (A) Indirect ELISA results showing total IgG antibody levels against PCV2d. The assay utilized inactivated PCV2d virus as the coating antigen. Serum samples from mice immunized with 5, 25, or 50 µg of rCapC, along with a control group, were collected at 0, 2, 4, 6, and 8 weeks post‐vaccination. (B) Indirect ELISA results showing total IgG antibody levels against PCV3. The assay utilized the full‐length PCV3 capsid protein expressed in E. coli as the coating antigen (rCap‐PCV3). For both panels, the y ‐axis shows optical density (OD) at 450 nm. Data are presented as the group mean ± SD. Statistical comparisons were performed using one‐way ANOVA followed by Tukey’s post hoc test. Groups sharing different superscript letters (a, b) above the bar differ significantly at each time point ( p < 0.05).

Journal: Transboundary and Emerging Diseases

Article Title: Porcine Circoviruses Type 2 and 3 Chimeric Novel Vaccine Candidate Formed Virus‐Like Particles and Induced Robust Immune Response in Mice

doi: 10.1155/tbed/4119771

Figure Lengend Snippet: Dose‐dependent specific IgG antibody responses against PCV2 and PCV3. (A) Indirect ELISA results showing total IgG antibody levels against PCV2d. The assay utilized inactivated PCV2d virus as the coating antigen. Serum samples from mice immunized with 5, 25, or 50 µg of rCapC, along with a control group, were collected at 0, 2, 4, 6, and 8 weeks post‐vaccination. (B) Indirect ELISA results showing total IgG antibody levels against PCV3. The assay utilized the full‐length PCV3 capsid protein expressed in E. coli as the coating antigen (rCap‐PCV3). For both panels, the y ‐axis shows optical density (OD) at 450 nm. Data are presented as the group mean ± SD. Statistical comparisons were performed using one‐way ANOVA followed by Tukey’s post hoc test. Groups sharing different superscript letters (a, b) above the bar differ significantly at each time point ( p < 0.05).

Article Snippet: Instead of the anti‐mouse IgG secondary antibody, HRP‐conjugated goat anti‐mouse IgG1 and IgG2a antibodies (1:5000 dilution; SouthernBiotech, Birmingham, AL, USA) were used.

Techniques: Indirect ELISA, Virus, Blood/Plasma/Serum Samples, Control

Humoral immune responses induced by rCapC vaccination against PCV2. Serum samples were collected at weeks 0, 2, 4, 8, 12, and 16 post‐immunization, and PCV2‐specific antibody responses were measured by indirect ELISA. (A) Total IgG, (B) IgG1, and (C) IgG2a levels are presented as optical density (OD 450 nm). Mice were immunized with rCapC, a commercial vaccine, or PBS as a negative control. Data are presented as the group mean ± SD. Statistical comparisons were performed using one‐way ANOVA followed by Tukey’s post hoc test. Groups sharing different superscript letters (a, b, c) above the bar differ significantly at each time point ( p < 0.05).

Journal: Transboundary and Emerging Diseases

Article Title: Porcine Circoviruses Type 2 and 3 Chimeric Novel Vaccine Candidate Formed Virus‐Like Particles and Induced Robust Immune Response in Mice

doi: 10.1155/tbed/4119771

Figure Lengend Snippet: Humoral immune responses induced by rCapC vaccination against PCV2. Serum samples were collected at weeks 0, 2, 4, 8, 12, and 16 post‐immunization, and PCV2‐specific antibody responses were measured by indirect ELISA. (A) Total IgG, (B) IgG1, and (C) IgG2a levels are presented as optical density (OD 450 nm). Mice were immunized with rCapC, a commercial vaccine, or PBS as a negative control. Data are presented as the group mean ± SD. Statistical comparisons were performed using one‐way ANOVA followed by Tukey’s post hoc test. Groups sharing different superscript letters (a, b, c) above the bar differ significantly at each time point ( p < 0.05).

Article Snippet: Instead of the anti‐mouse IgG secondary antibody, HRP‐conjugated goat anti‐mouse IgG1 and IgG2a antibodies (1:5000 dilution; SouthernBiotech, Birmingham, AL, USA) were used.

Techniques: Blood/Plasma/Serum Samples, Indirect ELISA, Negative Control

Antibody responses induced by rCapC vaccination against PCV3 in mice. Serum samples were collected at 0, 2, 4, 8, 12, and 16 weeks post‐vaccination. Antigen‐specific (A) IgG, (B) IgG1, and (C) IgG2a levels were measured by ELISA and expressed as optical density (OD) at 450 nm. Mice were immunized with rCapC (orange bars) or PBS (gray bars). Data are presented as the group mean ± SD. Statistical comparisons were performed using one‐way ANOVA followed by Tukey’s post hoc test. Groups sharing different superscript letters (a, b) above the bar differ significantly at each time point ( p < 0.05).

Journal: Transboundary and Emerging Diseases

Article Title: Porcine Circoviruses Type 2 and 3 Chimeric Novel Vaccine Candidate Formed Virus‐Like Particles and Induced Robust Immune Response in Mice

doi: 10.1155/tbed/4119771

Figure Lengend Snippet: Antibody responses induced by rCapC vaccination against PCV3 in mice. Serum samples were collected at 0, 2, 4, 8, 12, and 16 weeks post‐vaccination. Antigen‐specific (A) IgG, (B) IgG1, and (C) IgG2a levels were measured by ELISA and expressed as optical density (OD) at 450 nm. Mice were immunized with rCapC (orange bars) or PBS (gray bars). Data are presented as the group mean ± SD. Statistical comparisons were performed using one‐way ANOVA followed by Tukey’s post hoc test. Groups sharing different superscript letters (a, b) above the bar differ significantly at each time point ( p < 0.05).

Article Snippet: Instead of the anti‐mouse IgG secondary antibody, HRP‐conjugated goat anti‐mouse IgG1 and IgG2a antibodies (1:5000 dilution; SouthernBiotech, Birmingham, AL, USA) were used.

Techniques: Blood/Plasma/Serum Samples, Enzyme-linked Immunosorbent Assay

Overall animal experiments and immune evaluations in mice. Two independent mouse studies were conducted to evaluate the immunogenicity and efficacy of the rCapC vaccine candidate. Study 1 (dose‐finding, n = 5 per group): mice were intramuscularly (IM) immunized with different doses of rCapC (5, 25, or 50 μg/dose) formulated with ISA 201 adjuvant, while the control group received PBS. Primary and booster vaccinations were administered at weeks 0 and 2, respectively. Blood samples were collected at weeks 0, 2, 4, 6, and 8 to determine antigen‐specific IgG responses against PCV2 and rCap‐PCV3. Study 2 (efficacy test, n = 12 per group): mice were IM immunized with 25 μg rCapC (ISA 201), a commercial vaccine (ISA 206), or PBS control. Primary and booster vaccinations were given at weeks 0 and 2. Blood samples were collected at weeks 0, 2, 4, 8, 12, and 16. Humoral immune responses, including total IgG, IgG1, and IgG2a, were measured at all time points. Additionally, cellular immune responses (CD4 + T cells) and cytokine profiles were evaluated at selected time points (weeks 2 and 4).

Journal: Transboundary and Emerging Diseases

Article Title: Porcine Circoviruses Type 2 and 3 Chimeric Novel Vaccine Candidate Formed Virus‐Like Particles and Induced Robust Immune Response in Mice

doi: 10.1155/tbed/4119771

Figure Lengend Snippet: Overall animal experiments and immune evaluations in mice. Two independent mouse studies were conducted to evaluate the immunogenicity and efficacy of the rCapC vaccine candidate. Study 1 (dose‐finding, n = 5 per group): mice were intramuscularly (IM) immunized with different doses of rCapC (5, 25, or 50 μg/dose) formulated with ISA 201 adjuvant, while the control group received PBS. Primary and booster vaccinations were administered at weeks 0 and 2, respectively. Blood samples were collected at weeks 0, 2, 4, 6, and 8 to determine antigen‐specific IgG responses against PCV2 and rCap‐PCV3. Study 2 (efficacy test, n = 12 per group): mice were IM immunized with 25 μg rCapC (ISA 201), a commercial vaccine (ISA 206), or PBS control. Primary and booster vaccinations were given at weeks 0 and 2. Blood samples were collected at weeks 0, 2, 4, 8, 12, and 16. Humoral immune responses, including total IgG, IgG1, and IgG2a, were measured at all time points. Additionally, cellular immune responses (CD4 + T cells) and cytokine profiles were evaluated at selected time points (weeks 2 and 4).

Article Snippet: Instead of the anti‐mouse IgG secondary antibody, HRP‐conjugated goat anti‐mouse IgG1 and IgG2a antibodies (1:5000 dilution; SouthernBiotech, Birmingham, AL, USA) were used.

Techniques: Immunopeptidomics, Adjuvant, Control, Blood/Plasma/Serum Samples

Dose‐dependent specific IgG antibody responses against PCV2 and PCV3. (A) Indirect ELISA results showing total IgG antibody levels against PCV2d. The assay utilized inactivated PCV2d virus as the coating antigen. Serum samples from mice immunized with 5, 25, or 50 µg of rCapC, along with a control group, were collected at 0, 2, 4, 6, and 8 weeks post‐vaccination. (B) Indirect ELISA results showing total IgG antibody levels against PCV3. The assay utilized the full‐length PCV3 capsid protein expressed in E. coli as the coating antigen (rCap‐PCV3). For both panels, the y ‐axis shows optical density (OD) at 450 nm. Data are presented as the group mean ± SD. Statistical comparisons were performed using one‐way ANOVA followed by Tukey’s post hoc test. Groups sharing different superscript letters (a, b) above the bar differ significantly at each time point ( p < 0.05).

Journal: Transboundary and Emerging Diseases

Article Title: Porcine Circoviruses Type 2 and 3 Chimeric Novel Vaccine Candidate Formed Virus‐Like Particles and Induced Robust Immune Response in Mice

doi: 10.1155/tbed/4119771

Figure Lengend Snippet: Dose‐dependent specific IgG antibody responses against PCV2 and PCV3. (A) Indirect ELISA results showing total IgG antibody levels against PCV2d. The assay utilized inactivated PCV2d virus as the coating antigen. Serum samples from mice immunized with 5, 25, or 50 µg of rCapC, along with a control group, were collected at 0, 2, 4, 6, and 8 weeks post‐vaccination. (B) Indirect ELISA results showing total IgG antibody levels against PCV3. The assay utilized the full‐length PCV3 capsid protein expressed in E. coli as the coating antigen (rCap‐PCV3). For both panels, the y ‐axis shows optical density (OD) at 450 nm. Data are presented as the group mean ± SD. Statistical comparisons were performed using one‐way ANOVA followed by Tukey’s post hoc test. Groups sharing different superscript letters (a, b) above the bar differ significantly at each time point ( p < 0.05).

Article Snippet: Instead of the anti‐mouse IgG secondary antibody, HRP‐conjugated goat anti‐mouse IgG1 and IgG2a antibodies (1:5000 dilution; SouthernBiotech, Birmingham, AL, USA) were used.

Techniques: Indirect ELISA, Virus, Blood/Plasma/Serum Samples, Control

Humoral immune responses induced by rCapC vaccination against PCV2. Serum samples were collected at weeks 0, 2, 4, 8, 12, and 16 post‐immunization, and PCV2‐specific antibody responses were measured by indirect ELISA. (A) Total IgG, (B) IgG1, and (C) IgG2a levels are presented as optical density (OD 450 nm). Mice were immunized with rCapC, a commercial vaccine, or PBS as a negative control. Data are presented as the group mean ± SD. Statistical comparisons were performed using one‐way ANOVA followed by Tukey’s post hoc test. Groups sharing different superscript letters (a, b, c) above the bar differ significantly at each time point ( p < 0.05).

Journal: Transboundary and Emerging Diseases

Article Title: Porcine Circoviruses Type 2 and 3 Chimeric Novel Vaccine Candidate Formed Virus‐Like Particles and Induced Robust Immune Response in Mice

doi: 10.1155/tbed/4119771

Figure Lengend Snippet: Humoral immune responses induced by rCapC vaccination against PCV2. Serum samples were collected at weeks 0, 2, 4, 8, 12, and 16 post‐immunization, and PCV2‐specific antibody responses were measured by indirect ELISA. (A) Total IgG, (B) IgG1, and (C) IgG2a levels are presented as optical density (OD 450 nm). Mice were immunized with rCapC, a commercial vaccine, or PBS as a negative control. Data are presented as the group mean ± SD. Statistical comparisons were performed using one‐way ANOVA followed by Tukey’s post hoc test. Groups sharing different superscript letters (a, b, c) above the bar differ significantly at each time point ( p < 0.05).

Article Snippet: Instead of the anti‐mouse IgG secondary antibody, HRP‐conjugated goat anti‐mouse IgG1 and IgG2a antibodies (1:5000 dilution; SouthernBiotech, Birmingham, AL, USA) were used.

Techniques: Blood/Plasma/Serum Samples, Indirect ELISA, Negative Control

Antibody responses induced by rCapC vaccination against PCV3 in mice. Serum samples were collected at 0, 2, 4, 8, 12, and 16 weeks post‐vaccination. Antigen‐specific (A) IgG, (B) IgG1, and (C) IgG2a levels were measured by ELISA and expressed as optical density (OD) at 450 nm. Mice were immunized with rCapC (orange bars) or PBS (gray bars). Data are presented as the group mean ± SD. Statistical comparisons were performed using one‐way ANOVA followed by Tukey’s post hoc test. Groups sharing different superscript letters (a, b) above the bar differ significantly at each time point ( p < 0.05).

Journal: Transboundary and Emerging Diseases

Article Title: Porcine Circoviruses Type 2 and 3 Chimeric Novel Vaccine Candidate Formed Virus‐Like Particles and Induced Robust Immune Response in Mice

doi: 10.1155/tbed/4119771

Figure Lengend Snippet: Antibody responses induced by rCapC vaccination against PCV3 in mice. Serum samples were collected at 0, 2, 4, 8, 12, and 16 weeks post‐vaccination. Antigen‐specific (A) IgG, (B) IgG1, and (C) IgG2a levels were measured by ELISA and expressed as optical density (OD) at 450 nm. Mice were immunized with rCapC (orange bars) or PBS (gray bars). Data are presented as the group mean ± SD. Statistical comparisons were performed using one‐way ANOVA followed by Tukey’s post hoc test. Groups sharing different superscript letters (a, b) above the bar differ significantly at each time point ( p < 0.05).

Article Snippet: Instead of the anti‐mouse IgG secondary antibody, HRP‐conjugated goat anti‐mouse IgG1 and IgG2a antibodies (1:5000 dilution; SouthernBiotech, Birmingham, AL, USA) were used.

Techniques: Blood/Plasma/Serum Samples, Enzyme-linked Immunosorbent Assay

KRN2 inhibits NFAT5 and downregulates PD‐1 expression in CD8+ T cells. Note: (A) Workflow showing the isolation, activation, expansion, and grouping of CD8 + T cells from hPBMCs. Created using BioRender. (B) RT‐qPCR and Western blot analyses of NFAT5 and PD‐1 mRNA and protein expression levels. (C) RT‐qPCR and Western blot detection of NFAT5 and PD‐1 mRNA and protein expression following NFAT5 knockdown. (D) Dual‐luciferase reporter assay assessing the effect of NFAT5 on PD‐1 transcriptional activity. (E) ChIP assay examining NFAT5 binding to the PD‐1 promoter region. All experiments were independently repeated three times. ns, not significant; * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001.

Journal: Journal of Extracellular Vesicles

Article Title: CD8a‐Functionalized Red Blood Cell Membrane Nanovesicles Delivering KRN2 for Coordinated T Cell Reinvigoration and Macrophage Metabolic Reprogramming in Cardia Cancer

doi: 10.1002/jev2.70384

Figure Lengend Snippet: KRN2 inhibits NFAT5 and downregulates PD‐1 expression in CD8+ T cells. Note: (A) Workflow showing the isolation, activation, expansion, and grouping of CD8 + T cells from hPBMCs. Created using BioRender. (B) RT‐qPCR and Western blot analyses of NFAT5 and PD‐1 mRNA and protein expression levels. (C) RT‐qPCR and Western blot detection of NFAT5 and PD‐1 mRNA and protein expression following NFAT5 knockdown. (D) Dual‐luciferase reporter assay assessing the effect of NFAT5 on PD‐1 transcriptional activity. (E) ChIP assay examining NFAT5 binding to the PD‐1 promoter region. All experiments were independently repeated three times. ns, not significant; * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001.

Article Snippet: The isolated cells were first stimulated overnight with 2 μg/mL anti‐human CD3 antibody (A19017, ABclonal, China), followed by co‐stimulation with 2 μg/mL anti‐CD28 antibody (A20346, ABclonal, China) and recombinant human IL‐2 (rhIL‐2, 100 U/mL; #200‐02, PeproTech, USA) at 37°C for an additional 48 h. After stimulation, the cells were transferred to new culture plates containing fresh RPMI 1640 medium (11875093, Gibco, USA) supplemented with 10% fetal bovine serum (FBS), 1% penicillin‐streptomycin (15070063, Gibco, USA), and 1% L‐glutamine (25030081, Gibco, USA).

Techniques: Expressing, Isolation, Activation Assay, Quantitative RT-PCR, Western Blot, Knockdown, Luciferase, Activity Assay, Binding Assay, Cell Counting